Download TF1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Ending the Epidemic Task Force Recommendation Form
#1
COMPLETE
Collector: Web Link (Web Link)
Started: Sunday, October 26, 2014 8:28:50 AM
Last Modified: Sunday, October 26, 2014 8:46:20 AM
Time Spent: 00:17:29
IP Address: 68.194.182.51
PAGE 1
HIV Oral Testing
Q2: Title of your recommendation
Q3: Please provide a description of your proposed recommendation
To ensure that those at high risk have easy access to HIV testing in a supportive environment, all OASAS
licensed agencies should offer Oral HIV testing at agency sites at no cost to the consumer.
Q4: For which goal outlined in the Governor's plan
to end the epidemic in New York State does this
recommendation apply? (Select all that apply)
Identifying persons with HIV who remain
undiagnosed and linking them to health care
,
Linking and retaining persons diagnosed with
HIV to health care and getting them on anti-HIV
therapy to maximize HIV virus suppression so
they remain healthy and prevent further
transmission
,
Facilitating access to Pre-Exposure Prophylaxis
(PrEP) for high-risk persons to keep them HIV
negative
1/3
Ending the Epidemic Task Force Recommendation Form
Q5: This recommendation should be considered by
the following Ending the Epidemic Task Force
Committee (Select all that apply)
Prevention Committee: Develop
recommendations for ensuring the effective
implementation of biomedical advances in the
prevention of HIV, (such as the use of Truvada
as pre-exposure prophylaxis (PrEP)); for
ensuring access for those most in need to keep
them negative; and for expansion of syringe
exchange, expanded partner services, and
streamlined HIV testing by further implementing
the universal offer of HIV testing in primary care,
among others. The Committee will focus on
continuing innovative and comprehensive
prevention and harm reduction services targeted
at key high risk populations, as well as grantfunded services that engage in both secondary
and primary prevention.
,
Care Committee: Develop recommendations to
support access to care and treatment in order to
maximize the rate of HIV viral suppression. The
Committee will promote linkages and retention in
care to achieve viral suppression and promote
the highest quality of life while significantly
decreasing the risks of HIV transmission.
Recommendations will also ensure a person
centered approach is taken and that access to
culturally and linguistically appropriate
prevention and health care services is available.
Q6: Does this recommendation require a change to
an existing policy or program, or the creation of a
new policy or program?
Change to existing policy
Q7: Would implementation of this recommendation
be permitted under current laws or would a
statutory change be required?
Permitted under current law
Q8: Is this recommendation something that could
feasibly be implemented in the short-term (within
the next year) or long-term (within the next three to
six years)?
Within the next year
Q9: What are the perceived benefits of implementing this recommendation?
Early identification of HIV in substance users, increased linkage to care, early treatment .
Q10: Are there any concerns with implementing this recommendation that should be considered?
None. HIV testing already offered in all license primary care facilities as a mandate. Seems like we have
forgotten that substance abusers are more high risk for HIV then the general population?
2/3
Ending the Epidemic Task Force Recommendation Form
Q11: What is the estimated cost of implementing this recommendation and how was this estimate
calculated?
If you estimate the cost of not testing and missing an HIV Positive individual who could have been treated the
cost is minimal. The cost of the test kit.
Q12: What is the estimated return on investment (ROI) for this recommendation and how was the ROI
calculated?
I believe it is estimated that for every person who lives through the disease it cost close to 1 million dollars in
medical costs until death. ROI would be ten times less if diagnosis of HIV is in early onset.
Q13: Who are the key individuals/stakeholders who would benefit from this recommendation?
Substance abusers, persons with co-ocurring substance abuse and mental health, adolescents, those
individuals who would not reach out for testing, because of fear, stigma and cost and taxpayers.
Q14: Are there suggested measures to accompany this recommendation that would assist in
monitoring its impact?
yes, requiring that all licensed agencies OASAS and OMH licensed have Oral HIV testing offered and available
and that the availability and use of this service become part of the monitoring and oversight process for State
Regional Offices.
Q15: This recommendation was submitted by one of
the following
3/3
Advocate,
Other (please specify)
Member of the N/S Ryan White HIV Planning
Council